A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants
収録刊行物
-
- Hum Gene Ther.
-
Hum Gene Ther. 11 1453-1463, 2000